Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19Michael Pan, Toniemarie Catalan, Husam Shadid et al.|Journal of the American Heart Association|2021Cited by 29
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19Shengyuan Luo, Yiyuan Huang, Alexi Vasbinder et al.|Journal of the American Heart Association|2022Cited by 16